![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Watson Seeks Approval of Generic Version of Cancer Drug Velcade
Watson Seeks Approval of Generic Version of Cancer Drug Velcade
January 1, 2013
Watson Pharmaceuticals said it has applied for U.S. approval to market a generic version of Velcade (bortezomib), a treatment for multiple myeloma made by Takeda Pharmaceutical.
Reuters
Reuters
Upcoming Events
-
21Oct